Cargando…
Renal cancer biomarkers: the promise of personalized care
Significant advances in our understanding of the biology of renal cell carcinoma (RCC) have been achieved in recent years. These insights have led to the introduction of novel targeted therapies, revolutionising the management of patients with advanced disease. Nevertheless, there are still no bioma...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521191/ https://www.ncbi.nlm.nih.gov/pubmed/23016578 http://dx.doi.org/10.1186/1741-7015-10-112 |